홈
마켓
차트 & 아이디어
Algo
뉴스
Store
브로커
다운로드
경제 달력
트레이딩 시그널
웹터미널
검색
/
타입: @user, $symbol
검색
로그인
계정을 생성하십시오
한국어
English
Русский
中文
Español
Português
日本語
Deutsch
Français
Italiano
Türkçe
FEMY
#3687
Femasys Inc. Common Stock
0.5
7
0.00%
부문:
베이스:
수익 통화:
일일 변동 비율
년간 변동
일일 변동
0.00%
월간 변동
-3.39%
6달 변화
+50.00%
년간 변동율
-65.45%
이전 종가
0.5
7
Open
0.5
7
Bid
Ask
Low
0.5
7
High
0.5
7
양
5
마켓
주식
헬스케어
FEMY
Open full chart
Financials
Overview
성명
Statistics
Dividends
Quarterly
Annual
Value
2021
2022
2023
2024
TTM
Key stats
Total common shares outstanding
11.8 M
11.87 M
22.1 M
27.15 M
—
Valuation ratios
Enterprise value
21.25 M
-2.28 M
604.26 K
26.41 M
100.93 M
Price to earnings ratio
-3.48
-0.94
-1.09
-1.29
-4.28
Price to sales ratio
22.19
8.82
14.5
15.04
48.96
Price to cash flow ratio
-3.3
-0.99
-1.38
-1.26
-4.41
Price to book ratio
0.99
0.7
0.85
10.63
14.87
Enterprise value to EBITDA ratio
-2.75
0.21
-0.04
-1.62
-5.92
Profitability ratios
Return on assets %
-0.26
-0.67
-0.51
-1.51
-1.45
Return on equity %
-0.29
-0.75
-0.78
-8.17
-9.14
Return on invested capital %
-929.89
-1 343.28
-1 386.43
-919.33
-721.05
Gross margin %
68.6
63.36
64.54
66.55
253.62
Operating margin %
-706.7
-961.71
-1 353.43
-1 091.75
-3 854.16
EBITDA margin %
-655.02
-913.66
-1 297.16
-1 000.3
-3 459.99
Net margin %
-638.97
-944.62
-1 329.06
-1 155.03
-4 304.57
Liquidity ratios
Quick ratio
15.02
8.96
7.37
0.58
2.14
Current ratio
15.15
9.25
7.59
0.93
3.91
Inventory turnover
1.78
1.37
0.69
0.29
0.2
Asset turnover
0.04
0.05
0.05
0.08
0.15
Solvency ratios
Debt to assets ratio
—
—
—
—
—
Debt to equity ratio
—
—
—
—
—
Long term debt to total assets ratio
0
0.01
0.15
0
0.89
Long term debt to total equity ratio
0
0.01
0.23
0
6.98
Per share metrics
Operating cash flow per share
-1.18
-0.91
-0.73
-0.87
-0.7
EBIT per share
-1.24
-0.98
-0.94
-0.8
-0.65
EBITDA per share
-1.15
-0.93
-0.9
-0.73
-0.59
Total debt per share
—
—
—
—
—
Cash per share
3.69
1.1
1.41
0.16
0.53
Net current asset value per share
3.82
1.2
1.51
0.36
1.36
Tangible book value per share
3.92
1.29
1.19
0.1
0.34
Working capital per share
3.57
1.07
1.31
-0.03
-0.05
Book value per share
3.92
1.29
1.19
0.1
0.35
뉴스
Femasys receives CPT code approval for infertility treatment
Femasys, 스위스 유통 파트너십 소식에 주가 상승
Femasys expands European presence with Swiss distribution deal
Femasys, 나스닥 최저 입찰가 유지 위해 180일 연장 받아
Femasys granted 180-day extension by Nasdaq to meet minimum bid price rule
Femasys partners with Refuah Health Center to expand FemaSeed fertility treatment
Jonathan Schechter buys PharmaCyte Biotech shares worth $48,232
Pharmacyte Biotech CEO Silverman buys $80k in shares
Femasys receives FDA clearance for FemVue Controlled diagnostic device
파마사이테 바이오텍, Femasys 지분 매각 성공 후 급등
PharmaCyte Biotech stock soars after successful Femasys stake sale
PharmaCyte Biotech sells Femasys stake, boosts cash position to $20 million